Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

CVR Medical Corp V.CVM.H

Alternate Symbol(s):  CRRVF

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool, which complements other stroke screening technology such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA) and computed tomography angiography (CTA). The CSS is non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers.


TSXV:CVM.H - Post by User

Bullboard Posts
Comment by Looneytuneson Dec 06, 2018 4:36am
71 Views
Post# 29073946

RE:management cannot be trusted

RE:management cannot be trustedWhy would they look after us - they only ever look after themselves and regard PIs as a necessary evil hanging on to their coat tails. Have to say though that I am getting annoyed at how unnecessarily complex they seem to want to make everything; what is it about all these f..ing warrants, and % over allocations etc . . .why cant they just keep it simple; issue a shed load of new shares at a specific price and just get on with the job of getting us to market and making us all (but especially them wealthy). What I read into the RNS is that they don't expect FDA submission until at least the end of the first quarter next year when the issue is completed. . . more delays and smoke-screens but I stay invested although now believe that in 12 months when I look back that there will have been no real increase in the SP, because every time it moves forward it will be pegged back by warrant releases.
Bullboard Posts